Real-world data for optimal single antiplatelet therapy during the chronic maintenance period after percutaneous coronary intervention: a nationwide study of Korea
Optimal single antiplatelet therapy (SAPT) during the chronic maintenance period after coronary stenting remains uncertain. Although HOST-EXAM demonstrated superiority of clopidogrel over aspirin, real-world evidence remains limited. Using the Korean Health Insurance Review and Assessment Service (HIRA) claims database...